Member

Amendment 15 seeks to require a review of whether the aspects that the administering authority and actuary must have regard to when carrying out the valuation and setting contribution rates are adequately defined by current regulations, including solvency and long-term cost effectiveness. The statutory guidance already sets out in detail what these terms mean and how funds should address solvency and long-term cost effectiveness in the funding strategy statement that all funds are required to publish. This guidance was published in January 2025, following extensive collaboration between the scheme advisory board, CIPFA and MHCLG.